Morgan Stanley’s Tradr 2X Long ALAB Daily ETF LABX Stock Holding History

Morgan Stanley’s Portfolio LABX Stock Details LABX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-288	Closed	-$716	–	8692
2026 Q1	$716	Buy	+288	New	+$1.49K	﹤0.01%	7532

Other funds holding LABX

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $237M AUM 90.26% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Dedeker Financial St. Louis Park, Minnesota $176M AUM

Morgan Stanley's LABX Position: Q2 2026 in Review

Morgan Stanley sold out of Tradr 2X Long ALAB Daily ETF (LABX) in Q2 2026, closing a stake of 288 shares — an estimated $716 sold.

Morgan Stanley first reported a position in LABX in Q1 2026 and held it in 1 quarter. The position peaked at $716 in Q1 2026. 12 funds tracked by Wall St. Rank hold LABX as of Q2 2026.

Morgan Stanley reported no remaining Tradr 2X Long ALAB Daily ETF position as of Q2 2026 after selling out during the quarter.
Morgan Stanley sold 288 Tradr 2X Long ALAB Daily ETF shares in Q2 2026, an estimated $716.
Morgan Stanley first reported a position in Tradr 2X Long ALAB Daily ETF in Q1 2026 and held it in 1 quarter.
Morgan Stanley's Tradr 2X Long ALAB Daily ETF position peaked at $716 in Q1 2026.
12 funds tracked by Wall St. Rank held Tradr 2X Long ALAB Daily ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.